Real-world evidence (RWE) plays a pivotal role in healthcare decision making, exerting a profound impact on regulatory approvals, health technology assessment (HTA) evaluations, policy formulation, and clinical guideline development. While RWE holds immense potential in shaping multi-dimensional aspects of healthcare, its implementation and utilization vary across different regions. Understanding regional contexts and strategies is crucial for fostering international research collaboration, accelerating medical innovation, and improving patient outcomes. The presenters will discuss the expanding significance of RWE in healthcare, with examples of experiences and practices observed in the United States (US), France, and China.

Sponsored by Analysis Group